Piecing together the puzzle of progression and mortality in Parkinson's disease

Br J Clin Pharmacol. 2012 Aug;74(2):264-6. doi: 10.1111/j.1365-2125.2012.04315.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antiparkinson Agents / therapeutic use*
  • Cognition / drug effects*
  • Cognition Disorders / drug therapy*
  • Depression / drug therapy*
  • Disability Evaluation*
  • Humans
  • Motor Activity / drug effects*
  • Parkinson Disease / drug therapy*

Substances

  • Antiparkinson Agents